Effects of erythropoietin preconditioning on rat cerebral ischemia-reperfusion injury and the GLT-1/GLAST pathway

Experimental and Therapeutic Medicine

Volumn 11, Issue 2, 2016, Pages 513-518

  Yu, Daihua ^a   Fan, Yuanhua ^b   Sun, Xude ^a   Yao, Linong ^a   Chai, Wei ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

Cerebral ischemia reperfusion; Erythropoietin; Glutamate aspartate transporter; Glutamate transporter 1

Indexed keywords

ERYTHROPOIETIN; EXCITATORY AMINO ACID TRANSPORTER; MESSENGER RNA; VESICULAR GLUTAMATE TRANSPORTER 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTERY CLAMP; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; BRAIN NERVE CELL; CONTROLLED STUDY; EXTERNAL CAROTID ARTERY; FUNCTIONAL ASSESSMENT; GENE EXPRESSION REGULATION; INCISION; INTERNAL CAROTID ARTERY; ISCHEMIC PRECONDITIONING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE FUNCTION; NONHUMAN; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIGHT COMMON CAROTID ARTERY; TUNEL ASSAY; WESTERN BLOTTING;

EID: 84951155652     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2919     Document Type: Article

References (28)

1. Koudstaal PJ, Stibbe J and Vermeulen M: Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke. BMJ 297: 1571-1574, 1988.
2. Clark RK, Lee EV, White RF, Jonak ZL, Feuerstein GZ and Barone FC: Reperfusion following focal stroke hastens inflammation and resolution of ischemic injured tissue. Brain Res Bull 35: 387-392, 1994.
3. Mitani A and Kataoka K: Critical levels of extracellular glutamate mediating gerbil hippocampal delayed neuronal death during hypothermia: Brain microdialysis study. Neuroscience 42: 661-670, 1991.
4. Keelan J, Bates TE and Clark JB: Differences in the amount of glutamate released by neonatal and adult synaptosomes under conditions of in vitro ischaemia/reperfusion. Biochem Soc Trans 24: 425S, 1996.
5. Semkova I, Schilling M, Henrich-Noack P, Rami A and Krieglstein J: Clenbuterol protects mouse cerebral cortex and rat hippocampus from ischemic damage and attenuates glutamate neurotoxicity in cultured hippocampal neurons by induction of NGF. Brain Res 717: 44-54, 1996.
6. Perego C, Vanoni C, Bossi M, Massari S, Basudev H, Longhi R and Pietrini G: The GLT-1 and GLAST glutamate transporters are expressed on morphologically distinct astrocytes and regulated by neuronal activity in primary hippocampal cocultures. J Neurochem 75: 1076-1084, 2000.
7. Fukamachi S, Furuta A, Ikeda T, Ikenoue T, Kaneoka T, Rothstein JD and Iwaki T: Altered expressions of glutamate transporter subtypes in rat model of neonatal cerebral hypoxia-ischemia. Brain Res Dev Brain Res 132: 131-139, 2001.
8. Han BC, Koh SB, Lee EY and Seong YH: Regional difference of glutamate-induced swelling in cultured rat brain astrocytes. Life Sci 76: 573-583, 2004.
9. Harvey BK, Airavaara M, Hinzman J, Wires EM, Chiocco MJ, Howard DB, Shen H, Gerhardt G, Hoffer BJ and Wang Y: Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke. PLoS One 6: e22135, 2011.
10. Calapai G, Marciano MC, Corica F, Allegra A, Parisi A, Frisina N, Caputi AP and Buemi M: Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur J Pharmacol 401: 349-356, 2000.
11. Tang Z, Sun X, Shi Q, Wang X, Xie Y, Huo G, Zhou S and Liao Z: Beneficial effects of carbamylated erythropoietin against oxygen-glucose deprivation/reperfusion-induced astrocyte swelling: Proposed molecular mechanisms of action. Neurosci Lett 530: 23-28, 2012.
12. Longa EZ, Weinstein PR, Carlson S and Cummins R: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20: 84-91, 1989.
13. Shimakura A, Kamanaka Y, Ikeda Y, Kondo K, Suzuki Y and Umemura K: Neutrophil elastase inhibition reduces cerebral ischemic damage in the middle cerebral artery occlusion. Brain Res 858: 55-60, 2000.
14. Patt A, Rutherford RB, Pearce WH and Repine JE: Cerebral ischemia-reperfusion injury in the gerbil. J Surg Res 42: 462-466, 1987.
15. Tausompos C and Panoulis C: Tauοutouzas K, Zetaografos G and Papalois A: The effect of the antioxidant drug "U-74389G" on oophoritis during ischemia reperfusion injury in rats. Antiinflamm Antiallergy Agents Med Chem 13: 103-107, 2014.
16. Lehrke M and Lebherz C: AAV-mediated gene therapy for atherosclerosis. Curr Atheroscler Rep 16: 434, 2014.
17. Schlegel A, Kron P, Graf R, Dutkowski P and Clavien PA: Warm vs. cold perfusion techniques to rescue rodent liver grafts. J Hepatol 61: 1267-1275, 2014.
18. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM and Cerami A: Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci USA 97: 10526-10531, 2000.
19. Shin T, Ahn M, Moon C and Kim S: Erythropoietin and autoimmune neuroinflammation: Lessons from experimental autoimmune encephalomyelitis and experimental autoimmune neuritis. Anat Cell Biol 45: 215-220, 2012.
20. McCook O, Georgieff M, Scheuerle A, Möller P, Thiemermann C and Radermacher P: Erythropoietin in the critically ill: Do we ask the right questions? Crit Care 16: 319, 2012.
21. Grewer C, Gameiro A, Zhang Z, Tao Z, Braams S and Rauen T: Glutamate forward and reverse transport: From molecular mechanism to transporter-mediated release after ischemia. IUBMB Life 60: 609-619, 2008.
22. Akbar MT, Torp R, Danbolt NC, Levy LM, Meldrum BS and Ottersen OP: Expression of glial glutamate transporters GLT-1 and GLAST is unchanged in the hippocampus in fully kindled rats. Neuroscience 78: 351-359, 1997.
23. Persson M and Rönnbäck L: Microglial self-defence mediated through GLT-1 and glutathione. Amino Acids 42: 207-219, 2012.
24. Romera C, Hurtado O, Mallolas J, Pereira MP, Morales JR, Romera A, Serena J, Vivancos J, Nombela F, Lorenzo P, et al: Ischemic preconditioning reveals that GLT1/EAAT2 glutamate transporter is a novel PPARgamma target gene involved in neuroprotection. J Cereb Blood Flow Metab 27: 1327-1338, 2007.
25. Digicaylioglu M and Lipton SA: Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412: 641-647, 2001.
26. Um M and Lodish HF: Antiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathways. J Biol Chem 281: 5648-5656, 2006.
27. Byts N, Samoylenko A, Fasshauer T, Ivanisevic M, Hennighausen L, Ehrenreich H and Sirén AL: Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin. Cell Death Differ 15: 783-792, 2008.
28. Hosseinzadeh Z, Bhavsar SK, Sopjani M, Alesutan I, Saxena A, Dërmaku-Sopjani M and Lang F: Regulation of the glutamate transporters by JAK2. Cell Physiol Biochem 28: 693-702, 2011.